First Time Loading...

Modalis Therapeutics Corp
TSE:4883

Watchlist Manager
Modalis Therapeutics Corp Logo
Modalis Therapeutics Corp
TSE:4883
Watchlist
Price: 70 JPY -1.41% Market Closed
Updated: May 16, 2024

EV/EBITDA
Enterprise Value to EBITDA

-0.6
Current
-3.7
Median
4.3
Industry
Higher than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-0.6
=
Enterprise Value
1.3B
/
EBITDA
-2.3B
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
N/A
2-Years Forward
EV/EBITDA
-8.9
3-Years Forward
EV/EBITDA
N/A

See Also

Discover More